Small intestinal bacterial overgrowth in Parkinson's disease AH Tan, S Mahadeva, AM Thalha, PR Gibson, CK Kiew, CM Yeat, SW Ng, ... Parkinsonism & related disorders 20 (5), 535-540, 2014 | 303 | 2014 |
Helicobacter pylori infection is associated with worse severity of Parkinson's disease AH Tan, S Mahadeva, C Marras, AM Thalha, CK Kiew, CM Yeat, SW Ng, ... Parkinsonism & related disorders 21 (3), 221-225, 2015 | 152 | 2015 |
A requirement for FcγR in antibody-mediated bacterial toxin neutralization N Abboud, SK Chow, C Saylor, A Janda, JV Ravetch, MD Scharff, ... Journal of Experimental Medicine 207 (11), 2395-2405, 2010 | 118 | 2010 |
Amyloid β-peptide directly induces spontaneous calcium transients, delayed intercellular calcium waves and gliosis in rat cortical astrocytes SK Chow, D Yu, CL MacDonald, M Buibas, GA Silva ASN neuro 2 (1), AN20090035, 2009 | 97 | 2009 |
Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity S Bournazos, SK Chow, N Abboud, A Casadevall, JV Ravetch The Journal of clinical investigation 124 (2), 725-729, 2014 | 69 | 2014 |
Monoclonal antibodies and toxins—a perspective on function and isotype SK Chow, A Casadevall Toxins 4 (6), 430-454, 2012 | 66 | 2012 |
The effect of L-DOPA on Cryptococcus neoformans growth and gene expression HC Eisenman, SK Chow, KK Tsé, E McClelland, A Casadevall Virulence 2 (4), 329-336, 2011 | 61 | 2011 |
Prolonged detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in an obstetric patient with antibody seroconversion LP Molina, SK Chow, A Nickel, JE Love Obstetrics & Gynecology 136 (4), 838-841, 2020 | 60 | 2020 |
Cryptococcus Neoformans Galactoxylomannan is a Potent Negative Immunomodulator, Inspiring New Approaches in Anti-Inflammatory Immunotherapy A Vecchiarelli, E Pericolini, E Gabrielli, SK Chow, F Bistoni, E Cenci, ... Immunotherapy 3 (8), 997-1005, 2011 | 58 | 2011 |
Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans M De Jesus, A Moraes Nicola, SK Chow, IR Lee, S Nong, CA Specht, ... Virulence 1 (6), 500-508, 2010 | 52 | 2010 |
Evaluation of Cryptococcus neoformans galactoxylomannan–protein conjugate as vaccine candidate against murine cryptococcosis SK Chow, A Casadevall Vaccine 29 (10), 1891-1898, 2011 | 49 | 2011 |
Differential gene expression analysis in CCLE lesions provides new insights regarding the genetics basis of skin vs. systemic disease R Dey-Rao, JR Smith, S Chow, AA Sinha Genomics 104 (2), 144-155, 2014 | 45 | 2014 |
Role of CD45 signaling pathway in galactoxylomannan-induced T cell damage E Pericolini, E Gabrielli, G Bistoni, E Cenci, S Perito, SK Chow, F Riuzzi, ... PLoS One 5 (9), e12720, 2010 | 36 | 2010 |
Galactoxylomannans from Cryptococcus neoformans Varieties neoformans and grubii Are Structurally and Antigenically Variable M De Jesus, SK Chow, RJB Cordero, S Frases, A Casadevall Eukaryotic cell 9 (7), 1018-1028, 2010 | 34 | 2010 |
Fluorine-19 NMR chemical shift probes molecular binding to lipid membranes EY Chekmenev, SK Chow, D Tofan, DP Weitekamp, BD Ross, ... The Journal of Physical Chemistry B 112 (20), 6285-6287, 2008 | 33 | 2008 |
Identification and clinical significance of Helcococcus species, with description of Helcococcus seattlensis sp. nov. from a patient with urosepsis SK Chow, JE Clarridge III Journal of Clinical Microbiology 52 (3), 854-858, 2014 | 32 | 2014 |
The microbial capsular polysaccharide galactoxylomannan inhibits IL-17A production in circulating T cells from rheumatoid arthritis patients E Pericolini, A Alunno, E Gabrielli, E Bartoloni, E Cenci, SK Chow, ... PloS one 8 (1), e53336, 2013 | 25 | 2013 |
Combinations of monoclonal antibodies to anthrax toxin manifest new properties in neutralization assays MA Pohl, J Rivera, A Nakouzi, SK Chow, A Casadevall Infection and immunity 81 (6), 1880-1888, 2013 | 24 | 2013 |
Disease-enhancing antibodies improve the efficacy of bacterial toxin-neutralizing antibodies SK Chow, C Smith, T MacCarthy, MA Pohl, A Bergman, A Casadevall Cell host & microbe 13 (4), 417-428, 2013 | 24 | 2013 |
HTS-compatible patient-derived cell-based assay to identify small molecule modulators of aberrant splicing in myotonic dystrophy type 1 DA O’Leary, L Vargas, O Sharif, ME Garcia, YJ Sigal, SK Chow, ... Current Chemical Genomics 4, 9, 2010 | 22 | 2010 |